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Effective Treatment of Linear Darier’s Disease with Topical 
Retinoids: Case Report and Review of the Literature
Darier’s disease is a rare genodermatosis caused 
by a defect in ATP2A2 gene located on chromosome 
12q23-23 (1). This somatic mutation rarely occurs in 
the postzygotic phase of embryogenesis, leading 
to cutaneous mosaicism for the disease. The mosaic 
form of Darier’s disease is also called linear Darier’s 
disease and clinically presents with linear, zosteri-
form or localized patterns located on Blaschko’s lines. 
A case of linear Darier’s disease successfully treated 
with topical 0.1% tretinoin therapy is presented.
A 62-year-old male patient presented to derma-
tology department for scaly eruption on the back for 
over a month. The patient had undergone Whipple’s 
operation (pancreatoduodenosplenectomy) for pan-
creatic adenocarcinoma 3 months before. Dermato-
logic examination revealed unilateral follicular hy-
perkeratotic papules in an oblique linear configura-
tion over the patient’s back. Some keratotic papules 
coalesced to form plaques, which were located on 
Blaschko’s lines (Fig. 1). 
The remaining dermatologic examination of the 
hair, nails and mucosa was unremarkable. A punch 
biopsy performed from one of the papules showed 
focal suprabasilar acantholysis accompanied by dys-
keratotic keratinocytes both in the stratum spinosum 
and stratum corneum. Dyskeratotic cells in the stra-
tum spinosum showed pyknotic nuclei and enlarged 
homogeneous eosinophilic cytoplasm, whereas ba-
sophilic elongated nuclei were observed in dyskera-
totic cells of the stratum corneum (Fig. 2). They were 
consistent with corps ronds and grains previously de-
scribed in dyskeratotic dermatoses and particularly in 
Darier’s disease (2). With these histopathologic find-
ings, the diagnosis of Darier’s disease was made. The 
clinical presentation composed of localized plaques 
parallel to Blaschko’s lines led to the definitive diag-
nosis of linear Darier’s disease. Topical 0.1% tretinoin 
twice daily was prescribed and total improvement 
was accomplished after a month (Fig. 3).
Darier’s disease is a rare autosomal dominant 
genodermatosis which is caused by a defect in AT-
P2A2 gene on chromosome 12q23-23.1 (1). This gene’s 
product is a protein which functions as a sarco/endo-
plasmic reticulum calcium pumping ATPase isoform 2 
(SERCA2) and mutation of this protein leads to loos-
ening of the cell-cell adhesions by causing defect in 
the formation or maturation of the tonofilament-des-
mosome complex (3). The disrupted adhesion results 
in separation of the cells contributing particular focal 
suprabasilar acantholysis and dyskeratosis in kerati-
nocytes known as corps ronds and grains histopatho-
logically (2). The clinical findings in Darier’s disease 
include keratotic, crusted red-brownish papules dis-
tributed over the seborrheic areas such as the trunk, 
scalp margins, face and lateral aspects of the face. The 
papules generally coalesce to form large verrucous 
plaques. Nearly half of the patients have flat, shiny 
warty papules on the dorsal aspects of the hands. 
Painless whitish papules may be observed in oral mu-
cosa in 15% of patients (4). After reports of unilateral 
or zosteriform patterns in patients with Darier’s dis-
ease, the synonyms acantholytic dyskeratotic epider-
mal nevi, segmental Darier’s disease, linear Darier’s 
disease and localized Darier’s disease were started 
to be used for describing mainly the same localized 
clinical condition observed in Darier’s disease (5-7). 
In fact, 10% of patients with Darier’s disease are esti-
mated to have linear or zosteriform pattern, localized 
on one-half of the body and linear Darier’s disease is 
accepted as a mosaic form of Darier’s disease (8,9).
The reported treatment regimens for this rare mo-
saic cutaneous disorder are few in the literature. Topi-
cally applied adapalene was found to be effective by 
Cassals et al. (10). Short contact 0.1% tazarotene gel 
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Figure 1. Hyperkeratotic papules in linear and zosteriform configurations located on Blaschko’s lines over the back are seen 
on the left, and pinkish crusted papules seen on closer examination on the right.
Figure 2. Focal suprabasilar acantholysis is indicated with arrows on the left; dyskeratotic cells in stratum spinosum with pyk-
notic nuclei and enlarged homogeneous eosinophilic cytoplasm (corps ronds) are indicated with arrows, and dyskeratotic 
cells with basophilic elongated nuclei (grains) within stratum corneum are indicated with a circle on the right. (H&E x20 and 
x40 magnifications)
for 6 weeks treated the disease successfully (3). In our 
experience, topically applied 0.1% tretinoin cream 
was also able to treat the lesions after twice a day ap-
plication for 4 weeks. 
Tretinoin, also known as all-trans retinoic acid, is 
the acid form of vitamin A. In fact, all-trans retinoic 
acid is naturally formed by basal keratinocytes (11). 
Retinoids are believed to have antiproliferative ef-
fects on keratinocytes modulating keratinocyte dif-
ferentiation, normalizing abnormal differentiation, 
and down-regulating epidermal growth factor re-
ceptors and hyperproliferative keratins. They bind to 
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nuclear receptors RARs (retinoic acid receptors) or 
RXRs (retinoic X receptors) in cells and regulate gene 
expression by inhibiting transcription factors such 
as AP-1, which is a transcription complex controlling 
response to mitogenic injunctions (12). Retinoids 
also possess anti-inflammatory effects and they are 
shown to inhibit leukocytes, pro-inflammatory cy-
tokine release and transcription factor expression 
(13). Topical retinoids are preferably used for local-
ized cutaneous diseases for their low percutaneous 
absorption, rapid elimination and minor side effects. 
There are other local treatment options reported for 
Darier’s disease including 5-FU, cryotherapy and pho-
todynamic therapy, which obviously are not equally 
cost effective when compared to short-term topically 
applied retinoids (14,15).
Short periods of topically applied retinoids and 
retinoid analogues seem to be safe and effective for 
the treatment of linear Darier’s disease, which is etio-
logically accepted as an inherited dyskeratotic mosaic 
cutaneous disorder. 
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Generalized Pustular Psoriasis-Like Dermatophytosis  
due to Trichophyton rubrum
Trichophyton rubrum (T. rubrum) accounts for ap-
proximately 90% of chronic superficial dermatophyte 
infections in human host (1). In particular, it is fre-
quently implicated in tinea corporis caused by anthro-
pophilic fungi, in which it can produce large annular 
lesions with a poorly defined border and erythema or 
scaling (2). In 1968, Ive and Marks (3) used the term 
“tinea incognito” for cases of epidermomycosis, erro-
neously treated with topical steroids, having clinical 
manifestations that mimicked other skin conditions 
such as seborrheic dermatitis, lichen planus, folliculi-
tis, and rosacea (1). 
We reported on a patient with generalized tinea 
incognito caused by T. rubrum, who presented two 
weeks after being cured by fluconazole, with pustular 
psoriasis-like generalized tinea corporis.
A 56-year-old previously healthy woman presented 
to dermatology clinic (Faghihi Hospital, Shiraz, Iran) with 
a 2-year history of pruritic erythematous lesions involv-
ing the left leg, back, shoulders, right arm and forearm. 
The lesions were treated erroneously as eczema in three 
other medical centers, and she received topical cortico-
steroids, emollients and antihistamines. Her past medi-
cal history did not reveal any significant disease. In terms 
of drug history, she did not use any drug on regular basis 
except for the above-mentioned drugs.
On physical examination, erythematous, sharply 
demarcated lesions were observed on the above-
mentioned areas of her body (Fig. 1). Other physical 
examinations showed nothing abnormal. Routine 
laboratory tests were within the normal limits. Micro-
scopic examination of skin scrapings from the lesions 
with potassium hydroxide (KOH) revealed dermato-
phyte hyphae. T. rubrum was detected in the culture 
of skin scrapings. 
A course of 4-week fluconazole (150 mg daily) was 
started. The patient did not present to our clinic for 
follow up.
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Two weeks after ending the treatment course, the 
patient presented again to one of the above-men-
tioned dermatologic centers. They suspected pustular 
psoriasis and decided to start therapy with methotrex-
ate. Before starting the new treatment, the patient pre-
sented to our dermatologic clinic. On physical exami-
nation, previous lesions were found to have changed 
to well-demarcated and round plaques with scaling 
and pustules on the back, face, arms, and right leg (Fig. 
2). KOH smear and fungal culture indicated the diag-
nosis of T. rubrum dermatophytosis again, thus the pre-
vious 4-week course of fluconazole was reintroduced. 
After four weeks, complete resolution of all lesions was 
observed. Six-month follow up was normal.
Tinea corporis may be caused by either zoophilic 
fungi or anthropophilic organisms, less frequently 
by geophilic fungi (2). As a result of misdiagnosis or 
presence of pre-existing pathologies treated with 
local steroids, the clinical appearance of the lesions 
may mimic other skin conditions (1). Crawford et al. 
(4) report on not only corticosteroids but also new 
class topical non-steroidal medications including 
pimecrolimus and tacrolimus to have induced tinea 
incognito.
Generalized dermatophyte infections of the skin 
are typically observed in immunocompromised pa-
tients (e.g., patients receiving long-term immunosup-
pressive therapy, patients with HIV infection or with 
underlying lymphoproliferative disorders) (5). There 
are a few descriptions in the literature of widespread 
tinea corporis in immunocompetent patients (6), but 
there are some reports of widespread and chronic 
Figure 1. Erythematous, sharply demarcated lesions on the leg and back, with active margin and scaling surface.
Figure 2. Erythematous, well demarcated round plaques with scaling and pustules on the back and arm.
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dermatophyte infections in atopics (2) and in patients 
with Cushing’s syndrome (7).
The novel case described herein presented with 
pustular psoriasis-like generalized tinea corporis le-
sions. Serarslan (8) reports on a patient with tinea in-
cognito characterized by pustular inflammatory skin 
lesions after receiving steroid and emollient therapy, 
as in our patient. T. rubrum is a fungus that most fre-
quently induces both widespread dermatophytosis 
and atypical features and may cause pustular reac-
tion (2).
IIkit et al. (9) report on plaques with erythema and 
papules in the neck and breast area due to T. rubrum 
in a 20-year-old female. She was treated with corti-
costeroids for a long time. They conclude that tinea 
incognito could present in various clinical features, 
usually due to wrong treatment modalities. They sug-
gest investigation of fungi in atypical erythematous 
plaques. Kastelan et al. (10) report on a 72-year-old 
woman treated unsuccessfully with topical steroid 
cream for 3 months. Multiple nummular scaly pap-
ules and plaques were found on her arms and trunk. 
They describe circular and erythematous lesions with 
sharp demarcated and raised scaly edges. Finally, T. 
rubrum was cultured on Sabouraud’s agar. They sug-
gest that in patients previously treated with steroids, 
disseminated scaly infiltrate lesions should be inves-
tigated for fungal infection.
Although we treated our patient with fluconazole, 
terbinafine remains a good first-line treatment be-
cause T. rubrum is still highly sensitive to terbinafine 
(11). In conclusion, concerning clinical features of the 
case presented, dermatophyte infection may be con-
sidered on differential diagnosis of generalized pus-
tular dermatoses. 
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